MEDI-545: Clinical Trials

2 trials of MEDI-545, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow MEDI-545: new trials by email Literature Review of MEDI-545 trials Research Report on MEDI-545

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Safety of Multi-Dose MEDI-545 in Adult Patients With Dermatomyositis or Polymyositis
MEDI-545, Placebo - DERMATOMYOSITIS OR POLYMYOSITIS
Phase 1CompletedMedImmune LLC512008-04-012012-05-28
Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE)
MEDI-545, MEDI 545 - Lupus
Phase 1CompletedMedImmune LLC452006-03-012007-12-18

Conditions studied

Dermatomyositis (1)

Sponsors

MedImmune LLC (2)

Countries

United States (2)  ·  Canada (1)

Top investigators

Barbara White, M.D. (1)  ·  Dominique Ethgen, M.D. (1)

Results publications

PMID 19479852, PMID 21798883, PMID 23434567, PMID 33687069